These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36596954)

  • 1. Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients.
    Hoster C; Rahman A; Goyal A; Peigh G; Trohman R; Knight BP; Huang H; Krishnan K; Larsen T; Mazur A; Sharma P; Engelstein E; Verma N; Wasserlauf J
    J Interv Card Electrophysiol; 2023 Jan; ():. PubMed ID: 36596954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score.
    Quast ABE; Baalman SWE; Brouwer TF; Smeding L; Wilde AAM; Burke MC; Knops RE
    Heart Rhythm; 2019 Mar; 16(3):403-410. PubMed ID: 30292861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.
    Frankel DS; Burke MC; Callans DJ; Stivland TM; Duffy E; Epstein AE
    JACC Clin Electrophysiol; 2018 May; 4(5):652-659. PubMed ID: 29798794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study.
    Francia P; Biffi M; Adduci C; Ottaviano L; Migliore F; De Bonis S; Dello Russo A; De Filippo P; Viani S; Bongiorni MG; Caravati F; Lavalle C; Landolina ME; Pisanò E; Giorgi D; Lovecchio M; Valsecchi S; Diemberger I
    Europace; 2020 Dec; 22(12):1822-1829. PubMed ID: 33118017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial.
    Knops RE; El-Chami MF; Marquie C; Nordbeck P; Quast ABE; Tilz RR; Brouwer TF; Lambiase PD; Cassidy CJ; Boersma LVA; Burke MC; Pepplinkhuizen S; de Veld JA; de Weger A; Bracke FALE; Manyam H; Probst V; Betts TR; Bijsterveld NR; Defaye P; Demming T; Elders J; Field DC; Ghani A; Golovchiner G; de Jong JSSG; Lewis N; Marijon E; Martin CA; Miller MA; Shaik NA; van der Stuijt W; Kuschyk J; Olde Nordkamp LRA; Arya A; Borger van der Burg AE; Boveda S; van Doorn DJ; Glikson M; Kaiser L; Maass AH; van Woerkens LJPM; Zaidi A; Wilde AAM; Smeding L
    Heart Rhythm; 2024 Jun; 21(6):836-844. PubMed ID: 38336193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
    Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
    Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    Yamazaki K; Ishida Y; Sasaki S; Toyama Y; Nishizaki K; Kinjo T; Itoh T; Kimura M; Sakai S; Shikanai S; Sorimachi Y; Hamaura S; Tomita H
    J Cardiol; 2022 Nov; 80(5):482-486. PubMed ID: 35902323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is 40 Joules Enough to Successfully Defibrillate With Subcutaneous Implantable Cardioverter-Defibrillators?
    Biffi M; Bongiorni MG; D'Onofrio A; Manzo M; Pieragnoli P; Palmisano P; Ottaviano L; Perego GB; Pangallo A; Lavalle C; Bonfantino V; Nigro G; Landolina ME; Katsouras G; Diemberger I; Viani S; Bianchi V; Lovecchio M; Valsecchi S; Ziacchi M;
    JACC Clin Electrophysiol; 2021 Jun; 7(6):767-776. PubMed ID: 33516714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the PRAETORIAN score in a large subcutaneous implantable cardioverter-defibrillator collective: Usefulness in clinical routine.
    Doldi F; Frommeyer G; Löher A; Ellermann C; Wolfes J; Güner F; Zerbst M; Engelke H; Korthals D; Reinke F; Eckardt L; Willy K
    Heart Rhythm; 2024 Jul; 21(7):1057-1063. PubMed ID: 38382685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.
    de Veld JA; Pepplinkhuizen S; van der Stuijt W; Quast ABE; Olde Nordkamp LRA; Kooiman KM; Wilde AAM; Smeding L; Knops RE
    Europace; 2023 Jul; 25(7):. PubMed ID: 37379530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator.
    Rudic B; Tülümen E; Fastenrath F; Akin I; Borggrefe M; Kuschyk J
    Heart Rhythm; 2020 Mar; 17(3):455-459. PubMed ID: 31669771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.
    Amin AK; Gold MR; Burke MC; Knight BP; Rajjoub MR; Duffy E; Husby M; Stahl WK; Weiss R
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006665. PubMed ID: 30917689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients.
    Quast ABE; Baalman SWE; Van der Stuijt W; Wilde AAM; Knops RE
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2441-2447. PubMed ID: 31512339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
    Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
    Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of posture on position of subcutaneous implantable cardioverter-defibrillator.
    Pepplinkhuizen S; Spijkerboer AM; van der Stuijt W; de Veld JA; Dijkshoorn LA; Stenchlak ZE; Reijerink MAA; de Weger A; Smeding L; Olde Nordkamp LRA; Wilde AAM; Knops RE
    Heart Rhythm; 2024 Aug; ():. PubMed ID: 39103135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous ICD implantation.
    Calvo N; López-Perales CR; Olóriz T; Díaz-Cortegana F; Jáuregui B; Soto N; Rodríguez P; Santamaría E; Ortas MR; Asso A
    Pacing Clin Electrophysiol; 2024 Aug; ():. PubMed ID: 39099302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.
    Friedman DJ; Parzynski CS; Heist EK; Russo AM; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
    Circulation; 2018 Jun; 137(23):2463-2477. PubMed ID: 29463509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.
    Bänsch D; Bonnemeier H; Brandt J; Bode F; Svendsen JH; Felk A; Hauser T; Wegscheider K;
    Europace; 2015 Jan; 17(1):142-7. PubMed ID: 25107947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique.
    Okabe T; Savona SJ; Matto F; Ward C; Singh P; Afzal MR; Kalbfleisch SJ; Weiss R; Houmsse M; Augostini RS; Hummel JD; Daoud EG
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3027-3034. PubMed ID: 34554620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.